Fierce Biotech · Jul 15, 2026
J&J axes eye disease gene therapy after key phase 2b readout
Johnson & Johnson has stopped development of an eye disease gene therapy after reviewing data from one of its key readouts for 2026.
Latest medical news · page 69
The latest headlines across every section, pulled from official and open-access sources.
MHRA (UK) · Jul 15, 2026
Corporate report: Medicines and Healthcare Products Regulatory Agency Annual Report and Accounts 2025 to 2026
MHRA annual report and accounts 2025 to 2026.
Fierce Biotech · Jul 15, 2026
Why Axiom hopes it’s ‘solved 2 major potholes’ that have hurt other stem cell biotechs
When Axiom's stem cell therapy demonstrated a 0% mortality rate over two years in potentially fatal newborn neurological diseases this week, the biotech's leadership saw a broader validation for their approach to targeting the brain.
EMA (EU) · Jul 15, 2026
Executive Director Emer Cooke's speech at the European Parliament's Committee on Public Health
Brussels, 14 July 2026Check against delivery (The published text is based on the prepared speech. Minor differences may have occurred during delivery)Dear Ms Jerkovic, dear…
UKHSA (UK) · Jul 15, 2026
Guidance: Pathogen genomics at Porton Down
The Pathogen Genomics Department at Porton Down provides a sequencing service for SARS-CoV-2 for customers across the NHS and UKHSA.
MedTech Dive · Jul 15, 2026
SS Innovations names Sarah Romano as CFO
Romano, who is joining from rival robotic surgery company Vicarious Surgical, will step into a position that has been held by a series of executives over the past year.
UKHSA (UK) · Jul 15, 2026
Policy paper: Framework agreement between DHSC and the UK Health Security Agency: 2026 to 2029
Describes the working relationship between the Department of Health and Social Care and the UK Health Security Agency.
KFF Health News · Jul 15, 2026
Facing Funding Losses, States Call Out Big Businesses With Employees on Medicaid
With the federal Medicaid work requirements looming in January, Democrats are considering state legislation to call out big companies that employ workers enrolled in the safety net health program. Business giants such as Amazon and Walmart said the figures are misleading.
Fierce Biotech · Jul 15, 2026
Medtronic recalls catheter delivery system that may detach and cause death
Medtronic issued a voluntary recall of 102 lots of its Harmony delivery catheter system due to a risk that their tips may detach, which could result in serious injury or death.
UKHSA (UK) · Jul 15, 2026
Guidance: UKHSA FluSurvey surveillance system
Information on the FluSurvey surveillance system data.
UKHSA (UK) · Jul 15, 2026
'It looks done': Common BBQ blunders and how to avoid them
Simple advice from the FSA will help you avoid the grilling gaffes and common mistakes which could make it a memorable summer for all the wrong reasons.
DHSC (UK) · Jul 15, 2026
Official Statistics: UK Clinical Research Delivery key performance indicators: data to June 2026
Report bringing together data on the delivery of globally competitive clinical research through the UK Clinical Research Delivery programme.
UKHSA (UK) · Jul 15, 2026
Guidance: Bloodborne virus (BBV) related infection control breaches: management toolkit
This guidance supports risk assessment, investigation and management of infection control breaches, with a focus on BBV transmission.
Fierce Biotech · Jul 15, 2026
J&J MedTech growth slows again in Q2 as Abiomed weighs on results
Johnson & Johnson’s MedTech business posted operational sales growth of 3.6% in the second quarter, reaching $8.93 billion, as weaker Abiomed sales weighed on the unit’s performance.
UKHSA (UK) · Jul 15, 2026
Research: Tuberculosis in England, 2025 report
Incidence, treatment and prevention of tuberculosis (TB) in England using data up until the end of 2024.
Fierce Biotech · Jul 15, 2026
AAIC: Roche ‘very interested’ in testing tau for Alzheimer’s despite focus on phase 3-stage amyloid drug
Roche’s biggest bet in the Alzheimer’s disease space may be its phase 3-stage amyloid asset, but the Swiss pharma is keeping its options open when it comes to targeting tau.
MedCity News · Jul 15, 2026
How Fairview Health Services Turned Around a $315M Loss
Fairview Health Services turned a $315 million annual loss into a nearly $600 million turnaround in just two years. At the AHA Leadership Summit, CEO James Hereford broke down the strategy behind the comeback, from workforce redesign to frontline-driven process fixes. The post How Fairview Health Services Turned Around a $315M Loss appeared first on MedCity News .
Fierce Biotech · Jul 15, 2026
Attovia files for IPO to take on Sanofi and Regeneron’s Dupixent
Attovia Therapeutics has filed for an IPO to secure funding for assets, including a potential challenger to Sanofi and Regeneron’s Dupixent and Galderma’s Nemluvio.
CDC Emerging Infections · Jul 15, 2026
Detection of Highly Pathogenic Avian Influenza A(H5N1) Clade 2.3.4.4b Genotype D1.2 Virus in Swine after Experimental Inoculation
H. Seger et al.
CDC Emerging Infections · Jul 15, 2026
Outbreak of Salmonella enterica Serovar Reading Linked to Dried Bovine Meat, New South Wales, Australia, 2023
E. Kerr et al.
CDC Emerging Infections · Jul 15, 2026
Seeing Patterns—from Glass Art to Public Health
L. Mitchell and E. Belay
FDA MedWatch · Jul 15, 2026
Early Alert: Ventilator Issue from Resmed
Failure of an electrical component in certain Astral ventilators may cause an interruption or failure in therapy which may result in serious injury or death
CDC Emerging Infections · Jul 15, 2026
Occupationally Exposed and General Population Antibody Profiles to Influenza A Viruses Circulating in Swine as Indication of Zoonotic Risk
C. A. Snyder et al.
CDC Emerging Infections · Jul 15, 2026
Emergent Vibrio parahaemolyticus Gastroenteritis Outbreaks, New Zealand, 2019–2022
S. Jefferies et al.